|
2023
|
Invention
|
Pharmaceutical composition comprising a cap-dependent endonuclease inhibitor. Provided herein is ... |
|
|
Invention
|
Pharmaceutical composition comprising a cap-dependent endonuclease inhibitor.
The present disclo... |
|
2021
|
Invention
|
Amorphous solid dispersion formulation. Provided is an amorphous solid dispersion containing a Ca... |
|
|
Invention
|
Amorphous solid dispersion formulation. The present disclosure provides an amorphous solid disper... |
|
|
Invention
|
Antiviral agents.
A compound of Formula (I) below, or a pharmaceutically acceptable salt, stereo... |
|
|
Invention
|
Stereoselective synthesis of intermediate for preparation of heterocyclic compound. Provided is a... |
|
2020
|
Invention
|
Quinolone carboxylic derivatives.
A compound of Formula (I) below, or a pharmaceutically accepta... |
|
|
Invention
|
Quinolone carboxylic derivatives. 1235677 are defined as in the SUMMARY section. Further disclose... |
|
|
Invention
|
Hepatitis b antiviral agents.
A compound of Formula (I) below, or a pharmaceutically acceptable ... |
|
|
Invention
|
Hepatitis b antiviral agents. A compound of Formula (I) below, or a pharmaceutically acceptable s... |
|
2019
|
Invention
|
Cap-dependent endonuclease inhibitors. 14256735671223345566771-62-62-61-62-61-61-61-63-203-205656... |
|
|
Invention
|
Cap-dependent endonuclease inhibitors. Provided is a compound of Formula (I) below, or a pharmace... |
|
2018
|
Invention
|
Trans-isomeric heterocyclic compounds and preparation thereof. 115355 cycloalkyl. The trans-isome... |
|
2017
|
Invention
|
Trans-isomeric heterocyclic compounds and preparation thereof. A trans-isomeric compound of formu... |
|
|
Invention
|
Solid dispersion formulation. A spray-dried solid dispersion containing a pharmaceutical compound... |
|
2015
|
Invention
|
Method of treating cancer and myocardial infarction. A method of sensitizing a cancer cell to a c... |
|
2011
|
Invention
|
Hcv protease inhibitors.
This invention relates to compounds of Formula (I), (II), or (III) show... |
|
2009
|
Invention
|
Stereoselective synthesis of piperidine derivatives. This invention relates to dialdehyde or dini... |
|
|
Invention
|
Stereoselective synthesis of piperidine derivatives.
This invention relates to dialdehyde or din... |
|
|
Invention
|
Lyophilization formulation. This invention relates to a pharmaceutical kit containing a lyophiliz... |
|
|
Invention
|
Hcv protease inhibitors. This invention relates to macrocyclic compounds shown in the specificati... |
|
|
Invention
|
Hcv protease inhibitors. This invention relates to macrocyclic compounds of formula (I) shown in ... |
|
|
Invention
|
Antibiotic drug.
This invention relates to a malic acid salt of (3S,5R)-7-[3-amino-5-methyl-pipe... |
|
|
Invention
|
Antibiotic drug. This invention relates to a malic acid salt of (3S, 5R)-7-[3-amino-5-methyl-pipe... |
|
|
Invention
|
Pneumonia treatment.
This invention relates to a method of treating pneumonia by orally administ... |
|
|
Invention
|
Pneumonia treatment. The invention relates to a method of treating pneumonia by orally administer... |
|
2008
|
Invention
|
Antimicrobial quinolones, their compositions and uses. Compounds having the general structure:
... |
|
|
Invention
|
Hcv protease inhibitors.
This invention relates to macrocyclic compounds of formula (I) or (II) ... |
|
|
Invention
|
Hcv protease inhibitors. This invention relates to macrocyclic compounds of formula (I) or (II) s... |
|
|
Invention
|
Heterocyclic compounds. This invention relates to heterocyclic compounds of the formulas shown in... |
|
|
Invention
|
Hcv protease inhibitors.
Compounds of formula (I):
Compounds of formula (I):
Compounds o... |
|
|
Invention
|
Hcv protease inhibitors. Pyrrolidine compounds as shown in the specification. Also disclosed is u... |
|
|
Invention
|
Treatment of antibiotic-resistant bacteria infection. This invention relates to a method of treat... |
|
|
Invention
|
Antimicrobial parenteral formulation |
|
|
Invention
|
Kinesin inhibitors.
This invention relates to the compounds of formula (I) shown below. Each var... |
|
|
Invention
|
Kinesin inhibitors. This invention relates to the compounds of formula shown in the specification... |
|
|
Invention
|
Hcv protease inhibitors.
This invention relates to the compounds of formula (I) shown below. Eac... |
|
|
Invention
|
Hcv protease inhibitors. This invention relates to the compounds of formula (I) shown below. Each... |
|
2007
|
Invention
|
Protease inhibitors.
This invention relates to treating an infection with a virus using protease... |
|
|
Invention
|
Hcv protease inhibitors. This invention relates to the peptide-like compounds of formula (I) as s... |
|
|
Invention
|
Antimicrobial parenteral formulation. This invention relates to a parenteral formulation containi... |
|
|
Invention
|
Polyamine compounds. This invention relates to methods for treating retinopathy and repairing tis... |
|
|
Invention
|
Synthesis of amino-protected cyclohexane-1,4-diyldimethanamine and its derivatives.
This inventi... |
|
|
Invention
|
Coupling process for preparing quinolone intermediates. Process for making 7-cycloamino-1-cyclopr... |
|
|
Invention
|
Malate salts, and polymorphs of (3s,5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydr... |
